Tetrahydrocannabinol

NEOGEN Launches Reveal® Q+ for Δ9-THC in Hemp

Retrieved on: 
Wednesday, July 28, 2021
Drugs, Psychoactive drugs, Euphoriants, Appetite stimulants, Entheogens, Organ systems, Cannabis, Cannabinoids, Tetrahydrocannabinol, Hemp, Cannabidiol

NEOGEN's new Reveal Q+ for 9-THC can precisely detect and report THC levels between 0.1% and 1.6%, providing fast, reliable, and on-demand crop monitoring.

Key Points: 
  • NEOGEN's new Reveal Q+ for 9-THC can precisely detect and report THC levels between 0.1% and 1.6%, providing fast, reliable, and on-demand crop monitoring.
  • "The addition of the ability to test for 9-THC to our Reveal Q+ portfolio puts the power in the hands of hemp farmers," says John Adent, NEOGEN's President and CEO.
  • Hemp has various uses, including rope and textiles, feed and grain, and cannabidiol (CDB), commonly used in body care products and supplements.
  • NEOGEN Corporation develops and markets comprehensive solutions dedicated to food and animal safety.

Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent

Retrieved on: 
Tuesday, July 27, 2021
Drugs, Euphoriants, Cannabinoid, Psychoactive drugs, Appetite stimulants, Entheogens, Yarrowia, Tetrahydrocannabinol, Patent, Branches of biology

SAN FRANCISCO, July 27, 2021 /PRNewswire/ -- Biomedican has received notification from the U.S. patent office that its first patent has been approved and will be issued in the coming months.

Key Points: 
  • SAN FRANCISCO, July 27, 2021 /PRNewswire/ -- Biomedican has received notification from the U.S. patent office that its first patent has been approved and will be issued in the coming months.
  • This is the first patent ever to be issued using Yarrowia Lipolytica to produce cannabinoids.
  • Enzymes which are converting CBGA into CBDA, CBCA and THCA are required for the presence of interaction of two phases: oil and water.
  • "Patenting the use of Yarrowia Lipolytica to produce cannabinoids gives Biomedican a significant competitive advantage in the biosynthesized cannabinoid market.

Yetibles Delta-8 Gummies Offering Distributorships at Champs Las Vegas Show

Retrieved on: 
Monday, July 26, 2021
Drugs, Psychoactive drugs, Euphoriants, Cannabinoids, Biocides, Pesticide, Soil contamination, Delta-8-Tetrahydrocannabinol, Tetrahydrocannabinol, Medical specialties

In the past year, delta-8 products have become commonly sold in gas stations, smoke shops and on the internet.

Key Points: 
  • In the past year, delta-8 products have become commonly sold in gas stations, smoke shops and on the internet.
  • The products are unregulated, and tests have shown that some contain contaminants like pesticides or metals, and little delta-8 or too much delta-9.
  • Honaker said Yetibles D8 are perfect for people that want the benefits of cannabinoids, but without the unwanted side effects.
  • The Champs Trade Show will be held at the Las Vegas Convention Center, July 27-31, 2021.

The Cannabinoid Institute Offering Medical Courses Cannabis Certification for Clinicians in Mexico

Retrieved on: 
Monday, July 26, 2021
Psychoactive drugs, Cannabis, Entheogens, Health sciences, Cannabis smoking, Antiemetics, Herbalism, Medicinal plants, Medical cannabis, Effects of cannabis, Legality of cannabis, Tetrahydrocannabinol

NEW YORK, July 26, 2021 /PRNewswire/ -- The Cannabinoid Institute (TCI) launched a Spanish version of their well-respected online medical cannabis training certification for Mexican physicians and other healthcare providers on Friday, July 23.

Key Points: 
  • NEW YORK, July 26, 2021 /PRNewswire/ -- The Cannabinoid Institute (TCI) launched a Spanish version of their well-respected online medical cannabis training certification for Mexican physicians and other healthcare providers on Friday, July 23.
  • TCI is focusing on helping physicians who prescribe cannabis in Mexico to meet the demands of their patients since both medical and recreational cannabis became legal this past month.
  • In the US and abroad, less than 10% of medical schools provide training in the endocannabinoid system and in medical cannabis.
  • The Cannabinoid Institute (TCI) is a global women-led medical cannabis education company that specializes in teaching science-driven, objective web-based and live education to physicians, nurses, mental health clinicians, and pharmacists by providing accredited certification programs and individual courses for clinicians.

Delta-8 Cigarettes Launched by Exhale Wellness

Retrieved on: 
Monday, July 26, 2021
Psychoactive drugs, Entheogens, Euphoriants, Medicinal plants, Drugs, Branches of biology, Cannabis smoking, Antiemetics, Tetrahydrocannabinol, Medical cannabis, Cannabis, Effects of cannabis

Recently, to expand in the market, Exhale launched its Delta-8 THC cigarettes .

Key Points: 
  • Recently, to expand in the market, Exhale launched its Delta-8 THC cigarettes .
  • As a result, many cannabis users are switching to Delta-8 THC, and, as demand increases, Exhale Wellness has them covered.
  • Most recently, Exhale launched Delta-8 THC cigarettes to meet this increased demand.
  • Exhale Wellness has created these Delta-8 THC cigarettes with a unique mild scent related to tobacco.

Delta-8 Pre Rolls Launched by Exhale Wellness

Retrieved on: 
Friday, July 23, 2021
Agriculture, Songs, Crops, Cannabinoids, Biofuels, Hemp, Herbs, Anticonvulsants, Delta-8-Tetrahydrocannabinol, Tetrahydrocannabinol, Exhale, Charlotte's Web

LOS ANGELES, July 23, 2021 /PRNewswire/ --Exhale Wellness is a hemp company that provides proficiently crafted, natural hemp-derived Delta-8 products.

Key Points: 
  • LOS ANGELES, July 23, 2021 /PRNewswire/ --Exhale Wellness is a hemp company that provides proficiently crafted, natural hemp-derived Delta-8 products.
  • For anyone who is looking for a premium, sustainable and ethical solution for their Delta-8 cravings, Exhale has them covered.
  • Most people dislike grinding weed and rolling; hence Exhale has launched its Delta-8 pre-rolls .
  • Exhale Wellness has led the Delta-8 THC market with its innovative and quality products.

THC BioMed Announces Shipment to Yukon

Retrieved on: 
Friday, July 23, 2021
Psychoactive drugs, Entheogens, Euphoriants, Medicinal plants, Drugs, Branches of biology, Appetite stimulants, Herbalism, Cannabis, Tetrahydrocannabinol, Medical cannabis, Effects of cannabis

VANCOUVER, BC, July 23, 2021 /PRNewswire/ -THC BioMed Intl Ltd. ("THC BioMed" or the "Company" is pleased to announced that it has completed its first shipment to Yukon Cannabis.

Key Points: 
  • VANCOUVER, BC, July 23, 2021 /PRNewswire/ -THC BioMed Intl Ltd. ("THC BioMed" or the "Company" is pleased to announced that it has completed its first shipment to Yukon Cannabis.
  • The shipment contains dried cannabis and cannabis cookies.
  • THC BioMed is one of Canada's oldest active licensed cannabis companies.
  • THC BioMedis a Cannabis Act Licensed Producer of medical and recreational cannabis.

THC BioMed Announces Shipment to Yukon

Retrieved on: 
Friday, July 23, 2021
Psychoactive drugs, Entheogens, Euphoriants, Medicinal plants, Drugs, Branches of biology, Appetite stimulants, Herbalism, Cannabis, Tetrahydrocannabinol, Medical cannabis, Effects of cannabis

VANCOUVER, BC, July 23, 2021 /PRNewswire/ -- THC BioMed Intl Ltd. ("THC BioMed" or the "Company" is pleased to announced that it has completed its first shipment to Yukon Cannabis. The shipment contains dried cannabis and cannabis cookies.

Key Points: 
  • VANCOUVER, BC, July 23, 2021 /PRNewswire/ --THC BioMed Intl Ltd. ("THC BioMed" or the "Company" is pleased to announced that it has completed its first shipment to Yukon Cannabis.
  • The shipment contains dried cannabis and cannabis cookies.
  • THC BioMed is one of Canada's oldest active licensed cannabis companies.
  • THC BioMedis a Cannabis Act Licensed Producer of medical and recreational cannabis.

IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC

Retrieved on: 
Thursday, July 22, 2021
Alternative medicine, Health, Other Health, Drugs, Cannabis, Tetrahydrocannabinol, Psychoactive drugs, Neurochemistry

India Globalization Capital, Inc. (the Company) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (USPTO) issued a patent (#11,065,225) for the treatment of Alzheimers disease entitled Ultra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimers Disease.

Key Points: 
  • India Globalization Capital, Inc. (the Company) (NYSE American: IGC) announced today that on July 20, 2021, the United States Patent and Trademark Office (USPTO) issued a patent (#11,065,225) for the treatment of Alzheimers disease entitled Ultra-Low dose THC as a potential therapeutic and prophylactic agent for Alzheimers Disease.
  • On May 25, 2017, IGC entered into an exclusive license agreement with USF with respect to the patent application and the associated research conducted on Alzheimers disease.
  • The granted patent relates to IGCs proprietary formulation intended to assist in the treatment of individuals living with Alzheimers disease.
  • India Globalization Capital, Inc. (IGC) engages in the development of cannabinoid-based therapies for indications such as Alzheimer's disease and pain.

Sunderstorm Introduces First-of-Its-Kind Scientifically-Backed Personal Dosing with NANO5 DNA

Retrieved on: 
Thursday, July 22, 2021
Medicinal plants, Entheogens, Euphoriants, Psychoactive drugs, Branches of biology, Drugs, Cannabis smoking, Herbalism, Cannabis, Medical cannabis, Tetrahydrocannabinol, Effects of cannabis

The product taps into the next big breakthrough in cannabis science by leveraging a simple, powerful truth: Cannabis Is Personal.

Key Points: 
  • The product taps into the next big breakthrough in cannabis science by leveraging a simple, powerful truth: Cannabis Is Personal.
  • NANO5 DNA is the first THC product to scientifically align with a consumer's unique genetic makeup to maximize the ability to enjoy an ideal experience with cannabis.
  • Genetically aligned cannabinoid formulations like NANO5 DNA match consumers with better experiences and outcomes from the first use," said Len May, CEO and Co-Founder of EndoCanna Health.
  • At launch, NANO5 DNA is available only in California through select dispensaries and delivery services, including Mother Nature's Remedy and Rebud Delivery.